What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.94%
Annual Rate
CNY 0.20Paid annual
Payout Ratio
0.0%Sustainable
Payback Period
47.6 yr
Last Ex-Dividend
Sep 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.62BCNY
692.39M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
20.00x
vs Medical Devices peers
Updated Oct 24, 2026
Revenue (TTM)
913.38MCNY
136.82M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
20.28%
vs Medical Devices peers
Updated Oct 24, 2026
Beta
0.4950x
vs all stocks
Updated Oct 24, 2026
52-Week Change
-3.71%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
4.62BCNY
692.39M · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
2.80BCNY
419.12M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
20.00x
vs Medical Devices peers
Updated Oct 24, 2026
Forward P/E
15.85x
vs Medical Devices peers
Updated Oct 24, 2026
Price to Sales (TTM)
4.90x
vs Medical Devices peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 5.06×.Updated Oct 24, 2026
Price to Book (MRQ)
2.45x
vs Medical Devices peers
Updated Oct 24, 2026
Enterprise to Revenue
3.06x
vs Medical Devices peers
Updated Oct 24, 2026
Enterprise to EBITDA
12.69x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 14.66×.Updated Oct 24, 2026
Gross Margin
54.24%
vs Medical Devices peers
Updated Oct 24, 2026
Profit Margin
20.28%
vs Medical Devices peers
Updated Oct 24, 2026
Operating Margin
15.67%
vs Medical Devices peers
Updated Oct 24, 2026
Return on Assets (TTM)
5.62%
vs Medical Devices peers
Updated Oct 24, 2026
Return on Equity (TTM)
10.48%
vs Medical Devices peers
Updated Oct 24, 2026
Revenue (TTM)
913.38MCNY
136.82M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
2.06CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
39.40%
vs Medical Devices peers
Updated Oct 24, 2026
Gross Profit (TTM)
480.72MCNY
72.01M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
190.90MCNY
28.60M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
185.22MCNY
27.75M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
121.20%
vs Medical Devices peers
Updated Oct 24, 2026
Operating Cash Flow (TTM)
280.57MCNY
42.03M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
96.72MCNY
14.49M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing Annual Dividend Rate
0.2000CNYUpdated Oct 24, 2026
Trailing Annual Dividend Yield
1.94%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 40%.Updated Oct 24, 2026
Revenue
806.91MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
401.59MCNYFY2025 · Dec 31, 2025
Gross Profit
405.32MCNYFY2025 · Dec 31, 2025
Operating Income
183.15MCNY
27.44M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
164.75MCNYFY2025 · Dec 31, 2025
Income Tax Expense
20.51MCNYFY2025 · Dec 31, 2025
Net Income
144.24MCNYFY2025 · Dec 31, 2025
EBIT
165.03MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
201.99MCNYFY2025 · Dec 31, 2025
Research & Development
62.78MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
67.36MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.57MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
7.03MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
275.13KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.3278CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.3278CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
445.06MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
445.06MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
144.24MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.64MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
86.40MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-68.82MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
771.98MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
144.24MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.35MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-19.60MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-40.60MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-155.22MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-124.40MCNYFY2025 · Dec 31, 2025
Sale of Investments
18.02MCNYFY2025 · Dec 31, 2025
Other Investing Activity
16.00CNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-261.60MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-31.96MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-16.59MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-48.55MCNYFY2025 · Dec 31, 2025
Shares Outstanding
447.44MSharesUpdated Oct 24, 2026
Float Shares
196.08MSharesUpdated Oct 24, 2026
% Held by Insiders
42.02%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
18.23%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
1.41BCNY
211.67M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
3.19CNYUpdated Oct 24, 2026
Total Debt (MRQ)
2.21MCNY
330.85K · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.0012x
vs Medical Devices peers
Updated Oct 24, 2026
Current Ratio (MRQ)
3.35x
vs Medical Devices peers
Updated Oct 24, 2026
Book Value per Share (MRQ)
4.09CNYUpdated Oct 24, 2026
Total Assets
2.35BCNY
351.53M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.85BCNYFY2025 · Dec 31, 2025
Total Liabilities
567.74MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
498.53MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
110.48MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
457.27MCNYFY2025 · Dec 31, 2025
Cash
551.83MCNYFY2025 · Dec 31, 2025
Cash Equivalents
21.06MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
572.88MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
941.03MCNYFY2025 · Dec 31, 2025
Accounts Receivable
112.17MCNYFY2025 · Dec 31, 2025
Inventory
184.73MCNYFY2025 · Dec 31, 2025
Accounts Payable
217.82MCNYFY2025 · Dec 31, 2025
Short-term Debt
1.35MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
4.33MCNYFY2025 · Dec 31, 2025
Long-term Debt
732.63KCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
37.48MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
319.60MCNYFY2025 · Dec 31, 2025
Retained Earnings
289.41MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.78BCNY
266.49M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
19.90MCNYFY2025 · Dec 31, 2025
52-Week Low
8.61CNYUpdated Oct 24, 2026
52-Week High
13.19CNYUpdated Oct 24, 2026
52-Week Change
-3.71%
vs all stocks
Updated Oct 24, 2026
Beta
0.4950x
vs all stocks
Updated Oct 24, 2026
50-Day MA
9.84CNYUpdated Oct 24, 2026
200-Day MA
10.95CNYUpdated Oct 24, 2026
Avg 10-Day Volume
8.38MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
8.23MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
0.5000CNYUpdated Oct 24, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Medical Devices peers (median 0.11×)Notable